Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb. [electronic resource]
Producer: 20170515Description: 1093-9 p. digitalISSN:- 1097-6809
- Angiogenesis Inducing Agents -- administration & dosage
- Animals
- Blood Flow Velocity
- Chemokine CXCL12 -- administration & dosage
- Disease Models, Animal
- Granulocyte-Macrophage Colony-Stimulating Factor -- pharmacology
- Hindlimb
- Inflammation Mediators -- metabolism
- Injections, Intramuscular
- Ischemia -- drug therapy
- Male
- Neovascularization, Physiologic -- drug effects
- Protein Engineering
- Quadriceps Muscle -- blood supply
- Rats, Wistar
- Recombinant Proteins -- pharmacology
- Recovery of Function
- Regional Blood Flow
- Time Factors
- Vascular Endothelial Growth Factor A -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.